EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudie

Effectiveness of narrowband ultraviolet B monotherapy versus combination therapy with systemic agents in patients with early‐stage mycosis fungoides and the association with plaque lesions

Yao Qin, Yuwei Lin, Zhuojing Chen, Qiuli Zhang, Yingyi Li, Yujie Wen, Ping Tu, Pei Gao, Yang Wang iD

Journal of Evidence-Based Medicine · 2024

DOI: 10.1111/jebm.12623 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Evidence-Based Medicine, 2024. Verfasst von Yao Qin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Mycosis Fungoides, Ultraviolet Therapy, Skin Neoplasms. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Capital Clinical Diagnosis and Treatment Technology Research and Transformation Application Program of China, National Key Research and Development Program, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Narrowband ultraviolet B (NB‐UVB) has been recommended as first‐line therapy for early‐stage mycosis fungoides (MF) in international guidelines. NB‐UVB can be used as monotherapy or part of a multimodality treatment regimen. There is limited evidence on the effectiveness and optimal patients of NB‐UVB in combination with systemic therapies in MF. We aimed to assess the effectiveness of the combination versus NB‐UVB monotherapy in early‐stage MF and if plaque lesion status was related to these effects.

Methods

This observational cohort study included 247 early‐stage MF patients who had received NB‐UVB combined with systemic therapies vs. NB‐UVB monotherapy from 2009 to 2021. The primary outcome was partial or complete response. Overall response rate and median time to response were calculated. Hazard ratios (HRs) were estimated using the Cox model.

Results

In 139 plaque‐stage patients, the response rate for combination therapy group was higher than that of monotherapy group (79.0% vs. 54.3%, p = 0.006). The adjusted HR for combination therapy compared with NB‐UVB monotherapy was 3.11 (95% CI 1.72–5.63). The combination therapy group also showed shorter time to response (4 vs. 6 months, p = 0.002). In 108 patch‐stage patients, the response rate and time to response in two treatment groups showed no significant difference. There was therefore an observed interaction with patients’ plaque lesion status for the effect size of NB‐UVB combination therapy. No serious adverse events were observed.

Conclusions

Adding systemic treatments to NB‐UVB did not improve the treatment outcome of patch‐stage patients, but it surpassed NB‐UVB monotherapy for early‐stage patients with plaques.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycosis FungoidesUltraviolet TherapySkin NeoplasmsHumansMaleFemaleMiddle AgedAdultCombined Modality TherapyAgedTreatment OutcomeRetrospective StudiesCohort Studies

Stichwörter der Autor:innen

combined modality therapymycosis fungoidesphototherapyultraviolet therapy

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China.
  • Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China.
  • National Clinical Research Center for Skin and Immune Diseases, Beijing, China.
  • NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China.
  • Clinical Research Institute, Institute of Advanced Clinical Medicine, Peking University, Beijing, China.
  • Department of Dermatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.

ORCID-Profile: Yang Wang

Förderung

  • Capital Clinical Diagnosis and Treatment Technology Research and Transformation Application Program of China
  • National Key Research and Development Program
  • National Key Research and Development Program of China

Zitieren

APA

Qin, Y., Lin, Y., Chen, Z., Zhang, Q., Li, Y., Wen, Y., Tu, P., Gao, P., & Wang, Y. (2024). Effectiveness of narrowband ultraviolet B monotherapy versus combination therapy with systemic agents in patients with early‐stage mycosis fungoides and the association with plaque lesions. Journal of Evidence-Based Medicine. https://doi.org/10.1111/jebm.12623

Vancouver

Qin Y, Lin Y, Chen Z, Zhang Q, Li Y, Wen Y, et al. Effectiveness of narrowband ultraviolet B monotherapy versus combination therapy with systemic agents in patients with early‐stage mycosis fungoides and the association with plaque lesions. Journal of Evidence-Based Medicine. 2024. doi:10.1111/jebm.12623

BibTeX
@article{Qin2024,
  author = {Qin, Yao and Lin, Yuwei and Chen, Zhuojing and Zhang, Qiuli and Li, Yingyi and Wen, Yujie and Tu, Ping and Gao, Pei and Wang, Yang},
  title = {Effectiveness of narrowband ultraviolet B monotherapy versus combination therapy with systemic agents in patients with early‐stage mycosis fungoides and the association with plaque lesions},
  journal = {Journal of Evidence-Based Medicine},
  year = {2024},
  doi = {10.1111/jebm.12623}
}
Kostenlos starten →